Global Chloroquine Phosphate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
According to our (Global Info Research) latest study, the global Chloroquine Phosphate market size was valued at US$ 123 million in 2023 and is forecast to a readjusted size of USD 54.2 million by 2030 with a CAGR of -11.1% during review period.
Middle East and Africa is the dominant market in the global Chloroquine Phosphate market in terms of value. Sanofi and Bayer are the two players with the largest sales share, occupying 9.24% and 8.36% of the market share in 2019, respectively. And It is worth of noticing that chloroquine phosphate used in COVID-2019 will occupy 24.58% of the market share in 2020.
This report is a detailed and comprehensive analysis for global Chloroquine Phosphate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Chloroquine Phosphate market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Chloroquine Phosphate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Chloroquine Phosphate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global Chloroquine Phosphate market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chloroquine Phosphate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chloroquine Phosphate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Bayer, Ipca Laboratories, Cipla, Teva Pharmaceuticals, Merck, AstraZeneca, Pharco Pharmaceuticals, Indofarma, Jayson Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Chloroquine Phosphate market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chloroquine Phosphate Injectable
Chloroquine Phosphate Oral
Market segment by Application
Malaria
COVID-19
Others
Major players covered
Sanofi
Bayer
Ipca Laboratories
Cipla
Teva Pharmaceuticals
Merck
AstraZeneca
Pharco Pharmaceuticals
Indofarma
Jayson Pharmaceuticals
AM-Europharma
Humax Pharmaceutical
Atlantic Pharmaceutical
Ace Pharmaceuticals BV
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chloroquine Phosphate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chloroquine Phosphate, with price, sales quantity, revenue, and global market share of Chloroquine Phosphate from 2019 to 2024.
Chapter 3, the Chloroquine Phosphate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chloroquine Phosphate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Chloroquine Phosphate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chloroquine Phosphate.
Chapter 14 and 15, to describe Chloroquine Phosphate sales channel, distributors, customers, research findings and conclusion.